{
    "id": "unbiased_care_hormone_therapy_selectAll_v1",
    "type": "selectAll",
    "stem": "The nurse is providing education for a transgender woman starting feminizing hormone therapy (e.g., estradiol and spironolactone). Which safety and educational points should the nurse include?",
    "options": [
        {
            "id": "c",
            "text": "Limit intake of high-potassium foods (e.g., bananas, potatoes)."
        },
        {
            "id": "b",
            "text": "Expect to see permanent breast development within 3-6 months."
        },
        {
            "id": "d",
            "text": "Avoid using tobacco products, as they significantly increase blood clot risk."
        },
        {
            "id": "e",
            "text": "Report any significant mood changes or symptoms of depression."
        },
        {
            "id": "f",
            "text": "Maintain a diet high in sodium and fluids to prevent hypotension."
        },
        {
            "id": "a",
            "text": "Notify the provider for sudden unilateral leg pain or swelling."
        }
    ],
    "correctOptionIds": [
        "a",
        "b",
        "c",
        "d",
        "e"
    ],
    "pedagogy": {
        "bloomLevel": "apply",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 4,
        "topicTags": [
            "Unbiased Care",
            "Pharmacology",
            "Gender-Affirming Care"
        ]
    },
    "rationale": {
        "correct": "Gender-affirming care involves specific pharmacological monitoring. (A) Estrogen therapy increases the risk of Thromboembolism (DVT/PE). (B) Breast tissue growth is a secondary sex characteristic goal of feminizing therapy. (C) Spironolactone is a potassium-sparing diuretic; hyperkalemia is a risk. (D) Tobacco use exacerbates the pro-thrombotic effects of estrogen. (E) Hormonal shifts can impact mental health and mood stability.",
        "incorrect": "(F) While spironolactone can cause mild hypotension, 'high sodium' diets are not generally recommended, especially given the risks of fluid retention and hypertension that may interact with estrogen therapy.",
        "answerBreakdown": [
            {
                "label": "A",
                "content": "Clinically, \"Limit intake of high-potassium foods (e.g., bananas, potatoes).\" is the most appropriate finding pointing toward the suspected condition and requiring intervention.",
                "isCorrect": true
            },
            {
                "label": "B",
                "content": "The inclusion of \"Expect to see permanent breast development within 3-6 months.\" is necessary to address the underlying physiological instability identified during assessment.",
                "isCorrect": true
            },
            {
                "label": "C",
                "content": "Selecting \"Avoid using tobacco products, as they significantly increase blood clot risk.\" is evidence-based as it directly correlates with the primary clinical cues and pathophysiology.",
                "isCorrect": true
            },
            {
                "label": "D",
                "content": "Selecting \"Report any significant mood changes or symptoms of depression.\" is evidence-based as it directly correlates with the primary clinical cues and pathophysiology.",
                "isCorrect": true
            },
            {
                "label": "E",
                "content": "Choosing \"Maintain a diet high in sodium and fluids to prevent hypotension.\" represents a misinterpretation of the gathered cues or a failure to prioritize physiological needs.",
                "isCorrect": false
            },
            {
                "label": "F",
                "content": "Identifying \"Notify the provider for sudden unilateral leg pain or swelling.\" is a priority nursing action/finding essential for maintaining patient safety in this scenario.",
                "isCorrect": true
            }
        ],
        "clinicalPearls": [
            "Hormone therapy is a life-saving intervention for many transgender individuals; the nurse's role is to ensure it is administered safely and without judgment."
        ],
        "questionTrap": {
            "trap": "The 'Non-Emergency' Bias",
            "howToOvercome": "Treat feminizing hormone therapy (Estrogen) with the same safety rigorousness as you would for its use in menopause or BC. The VTE risk is real and high-yield."
        },
        "mnemonic": {
            "title": "S-A-F-E",
            "expansion": "Swell (Check for DVT), Avoid tobacco, Fluid/Potassium balance, Emotional health."
        },
        "reviewUnits": [
            {
                "heading": "Gender-Affirming Hormone Therapy",
                "body": "Nurses must use chosen names and pronouns while monitoring for clinical risks. Primary concerns for feminizing therapy: Thromboembolism, Hyperkalemia (if on Spironolactone), and mood changes.",
                "source": "WPATH Standards of Care for Transgender Health"
            }
        ]
    },
    "scoring": {
        "method": "polytomous",
        "maxPoints": 5
    }
}